Skip to content
Screener

Prime Medicine PRME Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$37.73M-53.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$28.98M+39.5%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$7.76M+751%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$146.15M+75.8%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$43.3M+18.9%
Net income-$42.1M+19.9%
EPS (diluted)-$0.24+41.5%

Balance sheet

See full
Cash & equivalents$61.1M-9.4%
Total debt$112.5M-6.1%
Total equity$39.8M-34.6%
Total assets$249.0M-10.7%

Cash flow

See full
Operating cash flow-$41.0M+0.9%
CapEx$46.0K-97.1%
Free cash flow-$41.1M+4.4%

Valuation

See full
Market cap$558.64M-8.7%
Enterprise value$609.98M-8.2%

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-373.3%-1,281pp
Debt / equity2.8×+0.9×
Current ratio3.1×-0.5×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053883
(in thousands, except share and per share amounts)June 30,2026December 31,2025
Property and equipment, net17,07720,572
Operating lease right-of-use assets120,468126,177
Restricted cash13,69113,691
Other assets1,0001,000
Total assets$249,040$342,733
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$5,808$8,887

Item 1. Financial Statements (unaudited)

FAQ

What is Prime Medicine's other non-current assets?
Prime Medicine (PRME) reported other non-current assets of $1M in Q2 2026.
What is the long-term trend for Prime Medicine's other non-current assets?
Over 4 years (2021 to 2025), Prime Medicine's other non-current assets has grown at a -20.3% compound annual growth rate (CAGR), from $2.47M to $1M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Prime Medicine's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude